BUDGET IMPACT ANALYSIS OF THE CELL-BASED QUADRIVALENT INFLUENZA VACCINE IN THE GERMAN POPULATION USING A DYNAMIC TRANSMISSION MODEL APPROACH

被引：0

作者：

Cai, R. ^{[1
]}

Schwehm, M. ^{[2
]}

Joaquin, F. M. Q. ^{[3
]}

机构：

[1] IQVIA, Amsterdam, Netherlands

[2] ExploSYS GmbH, Leinfelden Echterdingen, Germany

[3] Seqirus, Summit, NJ USA

来源：

VALUE IN HEALTH | 2020年 / 23卷

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PRS25

引用

页码：S721 / S721

页数：1

共 50 条

[1] The Epidemiological and Economic Impact of a Cell-Based Quadrivalent Influenza Vaccine in Adults in the US: A Dynamic Modeling Approach
Nguyen, Van Hung
Hilsky, Yvonne
Mould-Quevedo, Joaquin
[J]. VACCINES, 2021, 9 (10)
[2] Modelling the Economic Impact of influenza Vaccine Programs with the Cell-Based Quadrivalent Influenza Vaccine and Adjuvanted Trivalent Influenza Vaccine in Canada
Nguyen, Van Hung
Roy, Bertrand
[J]. VACCINES, 2022, 10 (08)
[3] Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine
McGovern, Ian
Taylor, Alexandra
Sardesai, Aditya
Toro-Diaz, Hector
Haag, Mendel
[J]. EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 371 - 379
[4] Budget Impact Analysis of the Adjuvanted Quadrivalent Influenza Vaccine in the Elderly in Italy
Baldo, Vincenzo
Bellone, Marco
[J]. FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2022, 23 (01) : 69 - 83
[5] Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Children: A Narrative Review
Mould-Quevedo, Joaquin F.
Pelton, Stephen I.
Nguyen, Van Hung
[J]. VACCINES, 2023, 11 (10)
[6] Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial
Essink, Brandon J.
Heeringa, Marten
Jeanfreau, Robert J.
Finn, Daniel
Matassa, Vince
Edelman, Jonathan
Hohenboken, Matthew
Molrine, Deborah
[J]. PEDIATRICS, 2022, 150 (05)
[7] Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
Lamb, Yvette N.
[J]. DRUGS, 2019, 79 (12) : 1337 - 1348
[8] Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
Yvette N. Lamb
[J]. Drugs, 2019, 79 : 1337 - 1348
[9] A BUDGET-IMPACT ANALYSIS OF QUADRIVALENT INFLUENZA VACCINE USE IN THE UNITED STATES
Talbird, S. E.
La, E. M.
Poston, S. A.
Hogea, C. S.
[J]. VALUE IN HEALTH, 2017, 20 (05) : A73 - A73
[10] Cost-effectiveness and budget impact analysis for high dose quadrivalent influenza vaccine in the Italian elderly population
Rumi, Filippo
Basile, Michele
Cicchetti, Americo
[J]. GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2021, 8 : 105 - 113

← 1 2 3 4 5 →